Iron therapies, erythropoiesis stimulating agents (ESAs), and hypoxia inducible factor inhibitors (HIF-PHI) are used to treat anemia of chronic kidney disease (CKD).

A proinflammatory diet might increase anemia risk in patients with diabetic kidney disease. Anemia occurs more frequently in patients with diabetic kidney disease (DKD) who have a proinflammatory diet ...

Sickle cell disease advocates in East Texas say raising awareness and expanding education are critical steps toward improving ...

“Our launch of iron sucrose proves again that we remain committed to pioneering access to more affordable medicines for patients with chronic conditions,” said Keren Haruvi, President Sandoz North ...

The Global Anemia Treatment Market is projected to grow from USD 11.84 billion in 2024 to USD 22.45 billion by 2033, at a ...

Amin, a pediatric hematology and oncology expert at the Children's Hospital of Richmond at VCU, which is one of four comprehensive sickle cell centers in the state.

People increasingly turn to do-it-yourself healthcare amid long waits for medical appointments and a rise in self-care ...

According to the CDC, nearly 100,000 Americans have Sickle Cell Anemia, or 1 in every 265 African American births.

Nine of 10 people who have sickle cell disease in the U.S. are of African ancestry or identify as Black, according to studies ...

President Ferdinand R. Marcos Jr. on Sunday highlighted his administration’s commitment to universal healthcare during his ...

(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...